SYNDROME D'ACTIVATION MACROPHAGIQUE CHEZ L ... - Toubkal

[245] Hot A, Madoux MH, Viard JP, Coppéré B, Ninet J.Successful treatment of cytomegalovirus-associated hemophagocytic syndrome byintravenous immunoglobulins.Am J Hematol 2008;83:159—62.[246] Imashuku S.Systemic type Epstein-Barr virus-related lymphoproliferative diseases in children and youngadults: challenges for pediatric hemato-oncologists and infectious disease specialists.Pediatr Hematol Oncol 2007;24:563—8.[247] Henter J.I., Samuelsson-Horne A., Arico M., Egeler R.M., Elinder G. et al.Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy andbone marrow transplantationBlood 2002 ; 100 : 2367-2373[248] Horne A., Janka G., Maarten Egeler R., Gadner H., Imashuku S. et al. Haematopoieticstem cell transplantation in haemophagocytic lymphohistiocytosisBr. J. Haematol. 2005 ; 129 : 622-630[249 ]Horne A., Zheng C., Lorenz I., Lofstedt M., Montgomery S. et al.Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocyticlymphohistocytosis provides therapeutic guidanceBr. J. Haematol. 2005 ; 129 : 658-666[250]Schneider E.M., Lorenz I., Muller-Rosenberger M., Steinbach G., Kron M. et al.Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis butnormal expression of transcripts relevant to killer-cell-induced apoptosisBlood 2002; 100 : 2891-2898[251] Imashuku S.Systemic type Epstein-Barr virus-related lymphoproliferative diseases in children and youngadults: challenges for pediatric hemato-oncologists and infectious disease specialists.Pediatr Hematol Oncol 2007; 24:563—8.[252] Afssaps.Recommandations de bon usage des immunoglobulinesIV. 2009. Disponible sur http://www.afssaps.fr/Dossiersthematiques/Tarification-a-l-activite-T2Amedicaments/ Immunoglobulines/%28offset%29/8.[253] Kontopoulou T, Tsaousis G, Vaidakis E, Fanourgiakis P, Michalakeas E, Trigoni E, et al.Hemophagocytic syndrome in association with visceral leishmaniasis.Am J Med 2002; 113:439—40.225